Deng, K., Yao, J., Huang, J., Ding, Y., & Zuo, J. (2021). Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy. Transl Oncol.
Citação norma ChicagoDeng, Kun, Jingwei Yao, Jialu Huang, Yubo Ding, and Jianhong Zuo. "Abnormal Alternative Splicing Promotes Tumor Resistance in Targeted Therapy and Immunotherapy." Transl Oncol 2021.
MLA CitationDeng, Kun, et al. "Abnormal Alternative Splicing Promotes Tumor Resistance in Targeted Therapy and Immunotherapy." Transl Oncol 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.